Natura Biotechnol

Natura Biotechnologies is a research-driven biotechnology company focused on discovering and developing bioactive molecules from natural sources for metabolic and chronic diseases. The company utilizes a proprietary discovery platform to identify plant-derived compounds that modulate clinically validated targets such as GLP-1 and DPP-4. Their primary focus is on creating next-generation treatments for type 2 diabetes and obesity that offer improved safety profiles compared to synthetic alternatives. Natura Biotechnologies bridges the gap between traditional herbal knowledge and modern drug discovery through rigorous scientific validation and clinical research.